Literature DB >> 21629277

Mining for therapeutic gold.

Francis S Collins1.   

Abstract

A comprehensive and collaborative strategy to enable the investigation of new uses of approved and abandoned drug compounds could advance translational research.

Mesh:

Substances:

Year:  2011        PMID: 21629277      PMCID: PMC5101935          DOI: 10.1038/nrd3461

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  2 in total

Review 1.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

2.  The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics.

Authors:  Ruili Huang; Noel Southall; Yuhong Wang; Adam Yasgar; Paul Shinn; Ajit Jadhav; Dac-Trung Nguyen; Christopher P Austin
Journal:  Sci Transl Med       Date:  2011-04-27       Impact factor: 17.956

  2 in total
  36 in total

Review 1.  Pioneering government-sponsored drug repositioning collaborations: progress and learning.

Authors:  Donald E Frail; Madeleine Brady; K Jane Escott; Alison Holt; Hitesh J Sanganee; Menelas N Pangalos; Chris Watkins; Craig D Wegner
Journal:  Nat Rev Drug Discov       Date:  2015-11-20       Impact factor: 84.694

2.  Innovation in therapeutics development at the NCATS.

Authors:  Christine M Colvis; Christopher P Austin
Journal:  Neuropsychopharmacology       Date:  2014-01       Impact factor: 7.853

3.  Reengineering translational science: the time is right.

Authors:  Francis S Collins
Journal:  Sci Transl Med       Date:  2011-07-06       Impact factor: 17.956

4.  Drug Repurposing from an Academic Perspective.

Authors:  Tudor I Oprea; Julie E Bauman; Cristian G Bologa; Tione Buranda; Alexandre Chigaev; Bruce S Edwards; Jonathan W Jarvik; Hattie D Gresham; Mark K Haynes; Brian Hjelle; Robert Hromas; Laurie Hudson; Debra A Mackenzie; Carolyn Y Muller; John C Reed; Peter C Simons; Yelena Smagley; Juan Strouse; Zurab Surviladze; Todd Thompson; Oleg Ursu; Anna Waller; Angela Wandinger-Ness; Stuart S Winter; Yang Wu; Susan M Young; Richard S Larson; Cheryl Willman; Larry A Sklar
Journal:  Drug Discov Today Ther Strateg       Date:  2011

5.  Drug repurposing: far beyond new targets for old drugs.

Authors:  T I Oprea; J Mestres
Journal:  AAPS J       Date:  2012-07-24       Impact factor: 4.009

6.  A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C.

Authors:  Christopher Koh; Preeti Dubey; Ma Ai Thanda Han; Peter J Walter; H Martin Garraffo; Pallavi Surana; Noel T Southall; Nathaniel Borochov; Susan L Uprichard; Scott J Cotler; Ohad Etzion; Theo Heller; Harel Dahari; T Jake Liang
Journal:  Antiviral Res       Date:  2019-01-31       Impact factor: 5.970

Review 7.  Drug repurposing in oncology--patient and health systems opportunities.

Authors:  Francesco Bertolini; Vikas P Sukhatme; Gauthier Bouche
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

8.  Drug repurposing and the medicinal chemist.

Authors:  Jeffrey Aubé
Journal:  ACS Med Chem Lett       Date:  2012-05-24       Impact factor: 4.345

9.  The Rescue and Repurposing of Pharmaceuticals: Augmenting the Drug Development Paradigm.

Authors:  Michael D Reed
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

10.  Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnership.

Authors:  Scott J Weir; Louis J DeGennaro; Christopher P Austin
Journal:  Cancer Res       Date:  2012-01-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.